Savings from sub-groups?: Policy guidance and Alzheimer's disease treatments-Reference-Cited by-同舟云学术

Savings from sub-groups?: Policy guidance and Alzheimer's disease treatments

Published:2010-10 Issue:8 Volume:14 Page:664-668
ISSN:1279-7707
Container-title:The journal of nutrition, health & aging
language:en
Short-container-title:J Nutr Health Aging

Author:

McNamee Paul,Vanoli A.,Hutchings D.,Mckeith I.,Bond J.

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology,Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s12603-010-0313-5.pdf

Reference38 articles.

1. Masters CL, Beyreuther K. Science, medicine and the future: Alzheimer's disease. British Medical Journal 1998; 316: 446–448.

2. Birks JS, Grimley Evans J, Iakovidou V, Tsolaki M. Rivastigmine for Alzheimer's disease. The Cochrane Library, Chichester, UK: John Wiley & Sons Ltd, Issue 2, 2004.

3. Birks JS, Harvey R. Donepezil for dementia due to Alzheimer's disease (Cochrane Review). Cochrane Database of Systematic Reviews. Cochrane Library, Chichester, UK: John Wiley & Sons Ltd, Issue 1, 2006.

4. Olin J, Schneider L. Galantamine for dementia due to Alzheimer's disease (Cochrane Review). The Cochrane Library, Chichester, UK: John Wiley & Sons Ltd, Issue 2, 2004.

5. Tariot PN, Federoff HJ. Current treatment for Alzheimer's disease and future prospects. Alzheimer Disease & Associated Disorders 2003; 17: 105–113.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can we improve care for patients with dementia?;The journal of nutrition, health & aging;2011-08

2. Editorial;The journal of nutrition, health & aging;2010-10